Cargando…

Antiepidermal Growth Factor Receptor Monoclonal Antibodies: Applications in Colorectal Cancer

Patients with metastatic colorectal cancer have a poor prognosis and present a challenge to clinicians. The role of the antiepidermal growth factor receptor (EGFR) pathway in tumorogenesis and tumor progression has been well defined. This paper will review the use of anti-EGFR monoclonal antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azizi, Efat, Kittai, Adam, Kozuch, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472558/ https://www.ncbi.nlm.nih.gov/pubmed/23091721 http://dx.doi.org/10.1155/2012/198197

Ejemplares similares

Update in Antiepidermal Growth Factor Receptor Therapy in the Management of Metastatic Colorectal Cancer
por: Loong, Herbert H., et al.
Publicado: (2009)

Antiepidermal Growth Factor Receptor Therapy in Squamous Cell Carcinoma of the Head and Neck
por: Shaib, Walid, et al.
Publicado: (2012)

Targeted Antiepidermal Growth Factor Receptor (Cetuximab) Immunoliposomes Enhance Cellular Uptake In Vitro and Exhibit Increased Accumulation in an Intracranial Model of Glioblastoma Multiforme
por: Mortensen, Joachim Høg, et al.
Publicado: (2013)

Monoclonal Antibodies against Epidermal Growth Factor Receptor in Solid Tumors
por: Saba, Nabil F., et al.
Publicado: (2012)

Potential Prognostic and Diagnostic Application of a Novel Monoclonal Antibody Against Keratinocyte Growth Factor Receptor
por: Ceccarelli, Simona, et al.
Publicado: (2014)

Monoclonal antibodies and chimeric antigen receptor (CAR) T cells in the treatment of colorectal cancer
por: Jin, Ke-Tao, et al.
Publicado: (2021)

A novel therapeutic strategy of personalized medicine based on anti-epidermal growth factor receptor monoclonal antibodies in patients with metastatic colorectal cancer
por: Matsuhashi, Nobuhisa, et al.
Publicado: (2018)

Evaluating the treatment of metastatic colorectal cancer with monoclonal antibodies
por: Popa, C, et al.
Publicado: (2012)

Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers
por: Hwang, Kyusang, et al.
Publicado: (2021)

Anti-tumor necrosis factor-alpha monoclonal antibody suppresses colorectal cancer growth in an orthotopic transplant mouse model
por: Takasago, Takeshi, et al.
Publicado: (2023)

Anti-PRL-3 Monoclonal Antibody inhibits the Growth and Metastasis of colorectal adenocarcinoma
por: Sun, Shuning, et al.
Publicado: (2023)

Monoclonal antibody humanness score and its applications
por: Gao, Sean H, et al.
Publicado: (2013)

Monoclonal Antibodies to the Thyrotropin Receptor
por: Ando, Takao, et al.
Publicado: (2005)

Type 1 insulin-like growth factor receptor monoclonal antibody (HX-1162) treatment for liver cancer
por: Chen, Xue-Hui, et al.
Publicado: (2013)

Chimeric Monoclonal Antibody Cetuximab Targeting Epidermal Growth Factor-Receptor in Advanced Non-Melanoma Skin Cancer
por: Wollina, Uwe, et al.
Publicado: (2017)

Economic evaluation of monoclonal antibody in the management of colorectal cancer in Malaysia
por: Natrah, MS, et al.
Publicado: (2012)

The Use of Epidermal Growth Factor Receptor Monoclonal Antibodies in Squamous Cell Carcinoma of the Head and Neck
por: Russell, Jeffery S., et al.
Publicado: (2012)

Monoclonal antibody against the fusion junction of a deletion-mutant epidermal growth factor receptor.
por: Okamoto, S., et al.
Publicado: (1996)

Therapeutic Applications of Monoclonal Antibodies
por: Berger, Mitchell, et al.
Publicado: (2002)

Monoclonal antibodies to human colon and colorectal carcinoma.
por: Thompson, C. H., et al.
Publicado: (1983)

Antitumor efficacy of triple monoclonal antibody inhibition of epidermal growth factor receptor (EGFR) with MM151 in EGFR-dependent and in cetuximab-resistant human colorectal cancer cells
por: Napolitano, Stefania, et al.
Publicado: (2017)

Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab
por: Hoda, Daanish, et al.
Publicado: (2008)

Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab
por: Williams, Kerry J, et al.
Publicado: (2009)

Erratum to: Insulin-like growth factor 1 receptor mediated tyrosine 845 phosphorylation of epidermal growth factor receptor in the presence of monoclonal antibody cetuximab
por: Iyer, Gopal, et al.
Publicado: (2016)

Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies
por: Diaz Miqueli, A, et al.
Publicado: (2009)

Inhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibody
por: Yin, Yongjun, et al.
Publicado: (2016)

Efficacy of the monoclonal antibody EGFR inhibitors for the treatment of metastatic colorectal cancer
por: Fakih, M., et al.
Publicado: (2010)

In vivo analysis of insulin-like growth factor type 1 receptor humanized monoclonal antibody MK-0646 and small molecule kinase inhibitor OSI-906 in colorectal cancer
por: LEIPHRAKPAM, PREMILA D., et al.
Publicado: (2014)

Impact of KRAS Mutations on Management of Colorectal Carcinoma
por: Sullivan, Kevin M., et al.
Publicado: (2011)

The Application Of Monoclonal Antibodies In The Study Of Viruses
por: Carter, Michael J., et al.
Publicado: (1984)

The pharmacology and therapeutic applications of monoclonal antibodies
por: Castelli, María Sofía, et al.
Publicado: (2019)

Detection of the growth fraction in colorectal tumours by a monoclonal antibody against DNA polymerase alpha.
por: Yamaguchi, A., et al.
Publicado: (1990)

Monoclonal Antibodies in Cancer
por: Ghosh, A.K.
Publicado: (1986)

An insulin growth factor-I/II-neutralizing monoclonal antibody in combination with epidermal growth factor receptor inhibitors potently inhibits tumor cell growth
por: Ma, Guofang, et al.
Publicado: (2022)

Affinity Maturation of an Epidermal Growth Factor Receptor Targeting Human Monoclonal Antibody ER414 by CDR Mutation
por: Chang, Ki-Hwan, et al.
Publicado: (2012)

Resistant metastatic penile carcinoma and response to biochemotherapy with paclitaxel and epidermal growth factor receptor monoclonal antibody, nimotuzumab
por: Pandey, Avinash, et al.
Publicado: (2013)

Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review
por: Leporini, Christian, et al.
Publicado: (2013)

Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cells
por: Saha, Nayanendu, et al.
Publicado: (2023)

Detection of Locally Recurrent Colorectal Cancer with Radiolabeled Monoclonal Antibody H‐15
por: Sakamoto, Junichi, et al.
Publicado: (1992)

Recent advances in targeted therapy of colorectal cancer: impacts of monoclonal antibodies nanoconjugates
por: Akbarzadeh Khiavi, Mostafa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_02p167ut2fbqd7ofogikch2r6q